
Loading, please wait...

Loading, please wait...

Vagus nerve stimulator (VNS) insertion serves as a vital treatment for children dealing with drug-resistant epilepsy. Initially, clinicians mandated overnight observation for these cases, but now same-day discharge VNS protocols are expanding because they improve hospital efficiency and lower costs. Therefore, rigorous safety assessments are required so that both providers and families feel confident in this rapid care model. Specifically, a recent study analyzed the National Surgical Quality Improvement Program-Pediatric (NSQIP-P) database to determine if early discharge correlates with higher readmission or reoperation rates. Ultimately, the researchers evaluated over 3,000 patients and found very positive safety results.
First, the study results found that only 2.1% of patients required an unplanned readmission within seven days of the procedure. Furthermore, there was no statistically significant difference in readmission rates between the same-day and inpatient cohorts. Moreover, multivariable analysis indicated that age, race, and anesthesia time did not negatively impact the results. Consequently, the data suggest that same-day discharge is safe for a diverse range of pediatric patients. Additionally, reoperation rates remained stable and low across both groups. Thus, inpatient stays are not always necessary for safety since clinicians can identify most issues early.
Because of these findings, surgical teams can now prioritize same-day protocols to streamline care. In summary, the transition to outpatient VNS surgery is safe and effective while reducing medical overhead. In addition, doctors should still monitor patients closely and provide clear instructions for home care. By doing so, they realize the benefits of same-day discharge VNS without any compromise in clinical quality. Furthermore, this approach also supports the growing demand for efficient pediatric surgical services and improved hospital resource management.
According to recent research, same-day discharge does not increase the risk of 7-day readmissions or reoperations. However, clinicians should still evaluate each patient's American Society of Anesthesiologists (ASA) classification and overall stability before sending them home.
Unplanned readmissions are relatively rare, occurring in approximately 2.1% of cases. While typical concerns include wound issues or seizure management, this specific study found no significant difference in rates between inpatient and outpatient cohorts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional physician-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
DiBiase J et al. Safety of same-day discharge following vagus nerve stimulator insertion in children: a National Surgical Quality Improvement Program study. J Neurosurg Pediatr. 2026 Apr 10. doi: 10.3171/2025.12.PEDS25501. PMID: 41962155.
Nationwide Children’s Hospital. Vagus Nerve Stimulation (VNS). [online] Available at: https://www.nationwidechildrens.org/family-resources-library/health-wellness-and-safety-resources/resources-for-parents-and-families/vagus-nerve-stimulation-vns
Cambridge University Hospitals NHS Foundation Trust. Vagus nerve stimulation therapy: patient discharge information (Paediatric). [online] Available at: https://www.cuh.nhs.uk/patient-information/vagus-nerve-stimulation-therapy-patient-discharge-information-paediatric/
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 3,070 pediatric patients confirms that same-day discharge after Vagus Nerve Stimulator insertion does not increase 7-day readmission rates....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today